CFL Hall of Famer and TSN analyst, Matt Dunigan, shares his experience with concussions. Plus, find out why he’s donating his brain to Dr. Charles Tator and the Canadian Concussion Centre.
Concussion Professorship: Dr. Carmela Tartaglia was appointed as the Marion and Gerald Soloway Professor in Brain Injury and Concussion Research on July 1, 2016, the first designated concussion professorship in the world.
Fellowship news: The Allison Project, started by Allison Haggart and her family, funded the first Concussion Fellow, a neurosurgeon, in 2012. Now, in 2016/2017, there are three Concussion Fellows at the CCC - two neurologists and one rehabilitation specialist - who have come to learn how to become concussion specialists.
Fifth Annual Concussion Research Symposium: Our annual symposium was held on January 17, 2017, and attended by approximately 160 participants. One of the Program Chairs was Dr. Carmela Tartaglia, recently appointed as The Soloway Professor of Concussion Research at the Toronto Western Hospital and University of Toronto. The presentations included two keynote speakers, Dr. Julian Bailes from NorthShore University and University of Chicago; Dr. Grant Iverson, of Harvard University and Massachusetts General Hospital; and 12 speakers from Ontario. There was a special presentation from Ken Dryden, as well as 10 poster presentations. We were able to update the participants on the progress being made by researchers at the Canadian Concussion Centre, at Toronto Western Hospital.
Education and Support Workshops: Our free two-night workshops are geared to individuals experiencing persistent post-concussive symptoms, and their families and friends. In order to reach a country-wide audience, we plan to expand, via YouTube, postings of the sessions. Workshops are held quarterly at The Toronto Western Hospital.
Learn more about our workshops.
Our Discoveries: New treatments for the concussion spectrum of disorders include psychological measures, such as mindfulness meditation and cognitive behavioural therapy; pharmacotherapy, for symptoms such as headache; and new devices for screen intolerance. Other targeted symptoms include eye movement disorders, vertigo/imbalance, whiplash and neck strains, sleeplessness, and mental health problems such as depression and anxiety.